| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/07/2004 | US20040197894 Comprises proteolytic polypeptide with enhanced wash performance, thermal stability, storage stability and catalytic activity for improving laundering and diswashing detergents |
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof |
| 10/07/2004 | US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy |
| 10/07/2004 | US20040197872 can be used in single or dual purpose and porcine reproductive respiratory syndrome virus vector vaccines; genetic engineering |
| 10/07/2004 | US20040197865 for detecting agonists of toll-like receptors/immune response modifier drugs genetic engineering |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197861 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 10/07/2004 | US20040197860 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 10/07/2004 | US20040197859 useful for treatment of migraine headaches/prophylaxis, menopausal hot flashes, chronic tension type headache, cluster headache, neurogenic or chronic inflammation, gastrointestinal disorders, type 2 diabetes and cardiovascular disorders |
| 10/07/2004 | US20040197854 nucleic acid construct integrates into the host genome at a locus not within the DNA sequence of interest to produce a mutant cell |
| 10/07/2004 | US20040197853 largely reduced of antigenicity compared to native trichosanthin (TCS), while retaining anti-tumor, anti-virus, abortifacient, and ribosome-inactivating protein activities; for treating leukemia |
| 10/07/2004 | US20040197842 for monitoring patients in vitro over time which can reveal changes in risk for hypercoagulation or other coagulopathies and/or effectiveness of anticoagulant therapy |
| 10/07/2004 | US20040197833 Binding of the CBDs (cell binding domain) to a solid phase and contacting with target cells; magnetic hydrophilic beads; hydrolases and lysins; use in detection, diagnosis and immobilization; biochips |
| 10/07/2004 | US20040197784 Comprises mammalian retinoid inducible carboxypeptidase for diagnosis, detection and treatment of vascular hyperplasia, restenosis, hhypertension and cardiovascular disorders; enzyme inhibitors |
| 10/07/2004 | US20040197783 Comprises nucleotide sequences coding modulator for treatment and prevention of tumor disorders; antisense/antitumor agents; immunotherapy |
| 10/07/2004 | US20040197773 derived from Kluyveromyces aestuarii; stereoselectivity; capable of converting 4-haloacetoaectate ester into optically active (S)-4-halo-3-hydroxybutyrate ester via reduced beta-nicotinamide adenine dinucleotide as electron donor |
| 10/07/2004 | US20040197772 catalyzes the hydrolysis of nitrile-containing substrates to carboxylic acids under mild reaction conditions; solid phase synthesis |
| 10/07/2004 | US20040197375 Composite scaffolds seeded with mammalian cells |
| 10/07/2004 | US20040197367 Composite scaffolds seeded with mammalian cells |
| 10/07/2004 | US20040197346 Materials and methods for intracellular transport and their uses |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus |
| 10/07/2004 | US20040197332 antiproliferative agents; antitumor and anticancer agents; monoclonal antibodies produced by hybridomas cell ling |
| 10/07/2004 | US20040197317 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 10/07/2004 | US20040197315 Parkinson's diisease; central nervous system disorders ; Alzheimer's disease; neurodegenerative disorders |
| 10/07/2004 | US20040197314 gene expression of polypeptide in membrane vesicle ; forming antibodies; controlling immunology response |
| 10/07/2004 | US20040197313 Promoter construct for gene expression in neuronal cells |
| 10/07/2004 | US20040197309 Schwann cells originating in myeloid interstitial cells |
| 10/07/2004 | US20040197308 Dna which controls gene expression; insertion of gene into tumor cells |
| 10/07/2004 | US20040197307 Mixture of human interferons |
| 10/07/2004 | US20040195710 Generating biocompatible microspheres; obtain macromolecule solution, mix biocompatible particles, form geometric shapes, expose shape to radiation, recover microspheres |
| 10/07/2004 | DE10311889A1 Zellpräparat und Verwendung des Präparats zur Behandlung von Gelenken und Knorpeldefekten, sowie Verfahren zur Herstellung Cell preparation and use of the preparation for the treatment of joints and cartilage defects, and methods for preparing |
| 10/07/2004 | DE10311620A1 Knorpelzell-Kulturmedium und Verwendung desselben The same cartilage cell culture medium and use |
| 10/07/2004 | CA2816489A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | CA2520722A1 Canine embryonic stem cells |
| 10/07/2004 | CA2520675A1 Identification, quantification, and characterization of t cells and t cell antigens |
| 10/07/2004 | CA2520445A1 Induction of differentiation of stem cells, and control of differentiation potency of stem cells |
| 10/07/2004 | CA2520390A1 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 10/07/2004 | CA2520273A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | CA2519528A1 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 10/07/2004 | CA2519488A1 Micro-cluster compositions |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464705A1 Optimizing cells for endogenous gene activation |
| 10/06/2004 | EP1464698A1 Human cell culture medium and culture method |
| 10/06/2004 | EP1464697A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements |
| 10/06/2004 | EP1464234A1 Method for the prevention or reduction of haze in beverages |
| 10/06/2004 | EP1463949A2 Diagnostics and vaccines for mycobacterium paratuberculosis infections |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463827A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/06/2004 | EP1463823A2 Methods of increasing endogenous erythropoietin (epo) |
| 10/06/2004 | EP1463822A2 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 10/06/2004 | EP1463821A1 In increasing gene transfer efficiency by pre-incubation with endothelial cells |
| 10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
| 10/06/2004 | EP1463816A2 Method for controlled induction of somatic mutations and use thereof in proteomics |
| 10/06/2004 | EP1463811A2 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 10/06/2004 | EP1463810A2 New glycosyl hydrolases |
| 10/06/2004 | EP1463806A2 Novel cyclooxygenase variants and methods of use |
| 10/06/2004 | EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 10/06/2004 | EP1463804A1 Improved gamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux |
| 10/06/2004 | EP1463803A2 Hematopoietic cells from human embryonic stem cells |
| 10/06/2004 | EP1463802A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos |
| 10/06/2004 | EP1463801A2 Transdifferentiation of pancreatic acinar cells |
| 10/06/2004 | EP1463800A2 Chondrocyte precursors derived from human embryonic stem cells |
| 10/06/2004 | EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells |
| 10/06/2004 | EP1463798A2 Islet cells from human embryonic stem cells |
| 10/06/2004 | EP1463797A2 Methods of kidney transplantation utilizing developing nephric tissue |
| 10/06/2004 | EP1463758A2 Mammal prolactin variants |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463755A2 Recombinant polypeptides |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463751A2 Albumin fusion proteins |
| 10/06/2004 | EP1463750A2 PLANT CYCLOPROPANE FATTY ACID SYNTHASE GENES, PROTEINS AND USES THEREOF |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463532A2 Dose response-based methods for identifying receptors having alterations in signaling |
| 10/06/2004 | EP1463522A1 Human antipneumococcal antibodies from non-human animals |
| 10/06/2004 | EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap |
| 10/06/2004 | EP1463479A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 10/06/2004 | EP1330647B1 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 10/06/2004 | EP1326968A4 Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells |
| 10/06/2004 | EP1185624B1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
| 10/06/2004 | EP1171470B1 Antibodies to placental protein 13 |
| 10/06/2004 | EP1149289B1 Whole cell selection utilizing azlactone-functional supports |
| 10/06/2004 | EP1073464B1 Monoclonal antibodies with reduced immunogenicity |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1012295B1 Alphavirus rna replicon systems |
| 10/06/2004 | EP0972017B1 Efficient nuclear transfer using fetal fibroblasts |
| 10/06/2004 | EP0949930B1 Thermostable phosphatases |
| 10/06/2004 | EP0862643B1 Accessory functions for use in recombinant aav virion production |
| 10/06/2004 | EP0833934B1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/06/2004 | EP0706563B1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 10/06/2004 | CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/06/2004 | CN1535312A PUFA polyketide synthase systems and uses thereof |
| 10/06/2004 | CN1535282A Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours |
| 10/06/2004 | CN1535164A Method for decellularising foreign material for production of bioprostheses |
| 10/06/2004 | CN1534096A Method of obtaining safety type anti yellow flower leaf disease frangenic wheat |
| 10/06/2004 | CN1169966C Isolated, tyrosinase derived peptides and uses thereof |
| 10/06/2004 | CN1169962C Plants which synthesize modified starch, method for producing plants, their use and modified starch |
| 10/06/2004 | CN1169959C Polypeptide variants with raised heparin-binding capacity |
| 10/06/2004 | CN1169948C Method for preparing biocompatible supporter, and supporter prepared thereby |
| 10/06/2004 | CN1169837C Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |